This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Justin A. Zivin, MD, PhD; Vincent Mazzarella

Arch Neurol. 1991;48(12):1235-1238.

Abstract
• Thrombolytic therapy is likely to be effective in some patients with stroke, but further improvements may require combination treatment with neuroprotective agents that can be given rapidly with relative safety. We tested the effects of tissue plasminogen activator (t-PA) with the glutamate antagonist MK-801 or the calcium channel blocker nimodipine in an embolic stroke model. We found that MK-801, followed by t-PA, was more effective than t-PA alone in reducing neurologic damage. Nimodipine plus t-PA was not better than t-PA alone. Combined glutamate antagonist and thrombolytic therapy may provide increased efficacy and safety for stroke treatment.

Author Affiliations
From the Department of Neurosciences, University of California at San Diego, La Jolla.

Footnotes
Accepted for publication April 9, 1991.

Reprint requests to Department of Neurosciences 0624, University of California at San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0624 (Dr Zivin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multimodal Neuroprotective Therapy With Induced Hypothermia After Ischemic Stroke
Hemmen and Lyden
Stroke 2009;40:S126-S128.
ABSTRACT | FULL TEXT  

Toward a Multimodal Neuroprotective Treatment of Stroke
Fisher et al.
Stroke 2006;37:1129-1136.
ABSTRACT | FULL TEXT  

Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Gladstone et al.
Stroke 2002;33:2123-2136.
ABSTRACT | FULL TEXT  

What have we learned from clinical neuroprotective trials?
Morgenstern
Neurology 2001;57:S45-47.
ABSTRACT | FULL TEXT  

An Overview of Acute Stroke Therapy: Past, Present, and Future
Fisher and Schaebitz
Arch Intern Med 2000;160:3196-3206.
FULL TEXT  

Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
Stroke 1999;30:2752-2758.
ABSTRACT | FULL TEXT  

Thrombolytic stroke therapy: Past, present, and future
Zivin
Neurology 1999;53:14-14.
ABSTRACT | FULL TEXT  

Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model • Editorial Comment
Andersen et al.
Stroke 1999;30:1464-1471.
ABSTRACT | FULL TEXT  

Synergistic Effects of a Combination of Low-Dose Basic Fibroblast Growth Factor and Citicoline After Temporary Experimental Focal Ischemia • Editorial Comment
Schabitz et al.
Stroke 1999;30:427-432.
ABSTRACT | FULL TEXT